Oncolytics Biotech Inc ONCY

Phase 2/3 OV company Genelux trades at US$35.00

[Noteable]

https://en.wikipedia.org/wiki/Genelux_Corporation

https://clinicaltrials.gov/ct2/show/NCT05281471

The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with platinum-doublet chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer (includes fallopian tube cancer and primary peritoneal cancer.

[Noteable]

In Genelux's Phase 2 clinical trial of 27 heavily pretreated patients with platinum-resistant or -refractory ovarian cancer (PRROC [platinum-resistant (n=14) or platinum-refractory (n=13)] and median 4 prior lines of therapy, Olvi-Vec followed by platinum-based chemotherapy ± bevacizumab as immunochemotherapy demonstrated objective response rate (ORR) of 54% and a median

[Noteable]

Results from ONCY's Bracelet-1 Phase 2 study in heavily pre-treated metastatic breast cancer patients treated with the single agent pelareorep + chemotherapy showed: - Pelareorep-paclitaxel combination reduced risk of disease progression by 71% (hazard ratio of 0.29) compared to paclitaxel monotherapy - 37.5% confirmed overall response rate with pelareorep-paclitaxel vs. 13.3% 

[Noteable]

Ask FUD if he's buying GNLX.

[fox7mf]

It would appear that Genelux has been a public company for all of 6 months...c'mon Coffey, make Oncy's 25th year its last. Sell now!!!!

[westcoast1000]

Yes, Genelux is a competitor and an interesting comparison. They are active in different indications than ONCY but parallels are striking. Note they had an IPO six months ago at $6 US. They have about 24 mil shares out. We are a bit over $2 US and have 63 mil shares out. The opportunity offered by Genelux at its IPO is comparable to the equity available in buying shares in ONCY at the current

[westcoast1000]

It is possible that the ongoing interest and price increase in Genelux is spilling over onto ONCY.

[Lesalpes29]

Probably something else. Volume is good since monday of last week. Something good is coming.

[Noteable]

Trading at US$36.50 today.

[Noteable]

Now trading at US$38.00

[fox7mf]

Wow. $37.8 usd...MC could take some lessons in shareholder value creation from these guys. Where, when, who & how much Matty?

[Noteable]

Instead those who are prone to criticisim fail to see the inherent value in ONCY as witnessed by this example.

[Noteable]

However their true critical character continues to shines through.

[Noteable]

In every post they make, they keep proving out their true critical nature of their negative character.

[Noteable]

Trading today at a high of US$40.00 per share - June 21, 2023

[inthno]

Thanks Note for the genelux information. I went to their website and they are actively enrolling in a phase 3 program....This helps show the potential for onc but also is another virus which could be considered direct competition. Their virus basically does exactly what our virus is supposed to do and they are moving ahead quickly at this point. Olvi-Vec, our lead product candidate, is a modified

[fox7mf]

I think many of us investors feel a little short changed at this point, particularly in light of how Matt pumped the next '6-9 months' back in November. The lack of positive news and movement brings on insecurities and angst. 

[Lesalpes29]

I think you right... Matt was very confident. Now he has to deliver. 

[Lesalpes29]

Fox it's probably because Matt has almost zero credibility! The rest of the board need to help him with that! 

[fox7mf]

On another, we continue to see fairly impressive and above average volume in the US. I don't know if this suggests slow accumulation, but maybe. 

[Lesalpes29]

Exactly Fox... slow and a more heavy accumulation? Could be.

[westcoast1000]

Noteable, Thanks for pointing out Genelux. I was not aware of that company.  This is a sincere question. Could you provide a quick statement on how that company differs from and/or is similar to ONCY? What do you think their investors see there to maintain their share price, while our share price and market cap is where it is? Are they ahead of us? Competitors of ours?  In general

[westcoast1000]

 correction:  of...Noteable (delete any)